Table of Contents
Analgesics in Mexico
Euromonitor International
September 2009
List
of Contents and Tables
Headlines
Trends
Competitive Landscape
Prospects
Sector Data
Table 1 Sales of Analgesics by Subsector: Value
2003-2008
Table 2 Sales of Analgesics by Subsector: % Value Growth
2003-2008
Table 3 Herbal vs Standard Topical Analgesics 2003-2008
Table 4 Topical Analgesics by Format: % Value Breakdown 2004-2008
Table 5
Analgesics Company Shares by Value 2004-2008
Table 6 Analgesics Brand
Shares by Value 2005-2008
Table 7 Forecast Sales of Analgesics by
Subsector: Value 2008-2013
Table 8 Forecast Sales of Analgesics by
Subsector: % Value Growth 2008-2013
Bayer De México SA De Cv
Strategic Direction
Key Facts
Summary 1 Bayer de México SA de CV:
Key Facts
Summary 2 Bayer de México SA de CV: Operational
Indicators
Company Background
Production
Summary 3 Bayer de
México SA de CV: Production Statistics 2007
Competitive
Positioning
Summary 4 Bayer de México SA de CV: Competitive Position
2008
Boehringer Ingelheim Promeco SA De Cv
Strategic Direction
Key
Facts
Summary 5 Boehringer Ingelheim Promeco SA de CV: Key Facts
Summary 6 Boehringer Ingelheim Promeco SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 7
Boehringer Ingelheim Promeco SA de CV: Competitive Position 2008
Farmacias
Similares SA De Cv
Strategic Direction
Key Facts
Summary 8
Farmacias Similares SA de CV: Key Facts
Summary 9 Farmacias Similares SA
de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 10 Farmacias Similares SA de CV:
Competitive Position 2008
Genomma Lab SA De Cv
Strategic Direction
Key Facts
Summary 11 Genomma Lab SA de CV: Key Facts
Summary 12
Genomma Lab SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 13 Genomma Lab SA de CV:
Competitive Position 2008
GlaxoSmithKline Plc
Strategic Direction
Key Facts
Summary 14 GlaxoSmithKline México SA de CV: Key Facts
Summary 15 GlaxoSmithKline México SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 16
GlaxoSmithKline México SA de CV: Competitive Position 2008
Merck-méxico SA
Strategic Direction
Key Facts
Summary 17
Merck-México SA: Key Facts
Summary 18 Merck-México SA:
Operational Indicators
Company Background
Competitive Positioning
Summary 19 Merck-México SA: Competitive Position 2008
Novartis
Farmacéutica SA De Cv
Strategic Direction
Key Facts
Summary
20 Novartis Farmacéutica SA de CV: Key Facts
Summary 21 Novartis
Farmacéutica SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 22 Novartis
Farmacéutica SA de CV: Competitive Position 2008
Pfizer SA De Cv
Strategic Direction
Key Facts
Summary 23 Pfizer SA de CV: Key
Facts
Summary 24 Pfizer SA de CV: Operational Indicators
Company
Background
Competitive Positioning
Summary 25 Pfizer SA de CV:
Competitive Position 2008
Procter & Gamble De México SA De Cv
Strategic Direction
Key Facts
Summary 26 Procter & Gamble de
México SA de CV: Key Facts
Summary 27 Procter & Gamble de México
SA de CV: Operational Indicators
Company Background
Production
Competitive Positioning
Summary 28 Procter & Gamble de México SA de
CV: Competitive Position 2008
Wyeth SA De Cv
Strategic Direction
Key Facts
Summary 29 Wyeth SA de CV: Key Facts
Summary 30 Wyeth SA de
CV: Operational Indicators
Company Background
Production
Summary
31 Wyeth SA de CV: Production Statistics 2007
Competitive Positioning
Summary 32 Wyeth SA de CV: Competitive Position 2008
Executive Summary
Sales of OTC Medication Grow at A Lower Pace
Mexican Regulations May Cause
Abrupt Changes
Many Leading Positions Threatened by Emerging Industry
Giant
Chained Outlets Are Taking Over the Distribution of Medications
Modest Growth Ahead
Key Trends and Developments
Mexican Regulation
Seeking Quality and Affordability in Medications
Mexicans Like To
Self-medicate
the Pharmaceutical Industry Faces Cost Pressures
Large
Distributors of Medications Are Expanding Throughout Mexico
A Giant Is
Making the OTC Industry Tremble
Market Indicators
Table 9 Consumer
Expenditure on Health Goods and Medical Services 2003-2008
Table 10 Life
Expectancy at Birth 2003-2008
Market Data
Table 11 Sales of OTC
Healthcare by Sector: Value 2003-2008
Table 12 Sales of OTC Healthcare by
Sector: % Value Growth 2003-2008
Table 13 OTC Healthcare Company Shares by
Value 2004-2008
Table 14 OTC Healthcare Brand Shares by Value
2005-2008
Table 15 Sales of OTC Healthcare by Distribution Format: %
Analysis 2003-2008
Table 16 Sales of OTC Healthcare by Sector and
Distribution Format: % Analysis 2008
Table 17 Forecast Sales of OTC
Healthcare by Sector: Value 2008-2013
Table 18 Forecast Sales of OTC
Healthcare by Sector: % Value Growth 2008-2013
Appendix
OTC
Registration and Classification
Vitamins & Dietary Supplements
Registration and Classification
Self-medication and Preventative
Medicine
Generics
Definitions
Summary 33 Research Sources
| 
View Cart
